Katherine Kumar

Dr. Kumar has led the development of numerous successful medical technologies. She is known for synchronizing regulatory and clinical operations to optimize reimbursement and ensure successful product commercialization. Her leadership in building efficient and adaptable management teams has been quintessential to the success of several med-tech startups with limited resources. Dr. Kumar is also a recognized thought leader in the globalization of clinical trials and is a frequent national speaker on the topic. She is credited as a key player in developing the first ever medical device Early Feasibility Study (EFS) study protocol in Japan, an accomplishment that will impact the entire medical device industry. Prior to 4C Medical, she served as Vice President of Clinical and Regulatory Affairs at TVA Medical, Inc. (currently Becton, Dickinson and Company), Vice President of Clinical Affairs at Monteris Medical, Inc., Senior Director of Science & Clinical Affairs at Cardiovascular Systems, Inc., and has held various operational roles within small start-up companies. Dr. Kumar currently serves as an advisor and is on the Board of Directors for several small start up companies.

Dr. Kumar earned her M.S., Ph.D. in Mechanical Engineering from University of North Carolina – Charlotte, completed the General Management Program at Harvard Business School and received Regulatory Affairs Certification (RAC).